ASHPOfficial

This podcast will discuss the impact that specialty pharmacy has made on their health system and how pharmacy is practiced, focusing on the how different groups utilize ambulatory and specialty pharmacy teams to meet the needs of our patients and our providers. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Other disciplines have used telehealth in the past with much success and the current healthcare landscape necessitates flexibility & innovation in delivery of care. This podcast will describe how pharmacists have incorporated telehealth into practice and how practitioners can use it to improve access to care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides an engaging interview with three outpatient pharmacist perspectives on the layered learning practice model. They will share insight into the benefits and challenges of incorporating a layered learning model in the outpatient setting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The podcast will discuss challenges with clinical decision support implementation, including common problems and solutions to ensure effective and timely implementation. We will cover working with third party data, maintenance considerations, prioritization and governance, and communication strategies to support implementation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast focuses on how to place value on the services that emergency medicine pharmacists provide and how to use that data to expand services in the emergency department. Both EM pharmacists and their leaders will find this podcast of value when evaluation services in your institution. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode featuring speakers from the ASHP Midyear Clinical Meeting in 2022, our content matter expert discusses the goals of emotional awareness and regulation and shares the key ingredients to becoming a reset master in your pharmacy practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of Practice Journeys, Juliana Zschoche shares her experiences working at a large outdoor music festival as a part of the Emergency Medical Team. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field about biosimilars in rheumatology and gastroenterology, biosimilar-related terms such as interchangeability and nocebo effect, and considerations unique to adalimumab biosimilars. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, the team from the Kettering Health to discuss their award-winning submission to the ASHP Best Practices. They will share how their COVID-19 treatment referral program has proven to be highly successful at addressing several challenges associated with outpatient treatment selection for patients with COVID-19 including fair allocation of resources, patient access to inventory, and drug-specific considerations through a pharmacist-driven and collaborative approach to care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Skin and soft tissue infections are commonly seen and treated in the emergency department. While most practitioners are comfortable with the typical infections it is important to consider unusual exposures and environmental factors that may result in atypical skin and soft tissue infections. This podcast will discuss some of these infections that may be seen due to exposures to water (salt & fresh) and soils and how to identify and manage these situations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pneumococcal vaccination recommendations are arguably some of the most difficult to maneuver. With the approval of two new pneumococcal vaccines, guidelines have significantly changed. This podcast aims to discuss these changes in vaccines and recommendations, and provide resources to ensure patients are receiving the right vaccine at the right time. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Recruiting and retaining pharmacists and pharmacy technicians has become increasingly challenging for pharmacy leaders. This podcast explores strategies for optimizing the pharmacy workforce, addressing recruitment and retention challenges, sharing success stories, and offering practical tips from two hospital pharmacy leaders. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode featuring technician focused programming at the Midyear Clinical Meeting our content matter experts describe successful elements of career ladder and share career ladders that have resulted in the retention of pharmacy technicians. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Population health is a growing practice setting within the field of pharmacy. Have you considered becoming involved with population health in your practice? If so, join us for this podcast where we hear from population health experts who have boots on the ground as it relates to management, billing/benefits, IT/analytics, and clinical pharmacy support roles in the field. After listening, we trust you’ll feel more ready to embark on your own population health venture. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

RX for Success focuses on pharmacy productivity and metrics in small and rural hospitals. We will be evaluating and discussing the differences between quantitative and qualitative metrics, survey results from commonly utilized metrics in small and rural hospitals throughout the country, and metrics that hold particular value to C-suite staff. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Residency programs often provide residents the opportunity to conduct medication use evaluations (MUE), drug utilization reviews (DUR), continuous quality improvement (CQI) reviews, and other research and quality projects. While all of these activities are valuable for the program and the resident, they are not interchangeable. This activity will compare various types of project methodologies, reviewing benefits and opportunities for each. The podcast will also shed some light on how some MUEs can evolve into research and the role of IRB. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides an engaging interview with three inpatient pharmacist perspectives on the layered learning practice model. They will share insight into the benefits and challenges of incorporating a layered learning model in the inpatient setting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Please join us on this week’s pharmacy leadership episode as leaders in the field provide insights and guidance on the peer review podcast. Hear their story of how they first got introduced to the peer review process and the benefits they experienced. In addition, they answer frequently asked questions one might have who is considering becoming a peer reviewer and why you too should consider trying it out! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, our Specialty Pharmacy content matter experts share best practices for compliance and maintenance of dual/tertiary specialty pharmacy accreditation including dual and tertiary certifications. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Gabriella Douglass – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. The episode will discuss their journey exploring and implementing WBR principles, while leading the way for their learners and organizations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, leaders from five different health system specialty pharmacies share examples of disasters and emergencies that their specialty pharmacies have encountered. Speakers will share their experiences, and describe the business continuity plans they implemented to sustain operations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will focus on the perspective of two clinical pharmacy specialists who have experience with developing clinical pharmacy services in either new pediatric emergency departments or established ones that never had a designated clinical pharmacist. This podcast episode will help future pharmacists prepare for the process of establishing new clinical services and receive helpful tips and tricks to be successful specifically in a pediatric emergency department. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode from the 2022 Midyear Clinical Meeting, our content matter experts discuss digital health interventions currently used by pharmacists and identify monitoring opportunities for pharmacists. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides listeners with an overview of how professional policies are developed within ASHP. Members from ASHP’s councils, the primary bodies that initiate ASHP policies on professional issues, discuss their roles and share ways new practitioners can get involved in supporting professional policy development. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode from the Midyear 2022 Clinical Meeting, our content matter experts summarize the rationale for the development of an organizational medication safety dashboard and provide real-world examples of metric design, data source identification, and data visualization for a medication safety dashboard. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Measles is a harmful yet preventable disease that carries multiple sequelae requiring hospitalization. Due to falsified and retracted literature, the measles vaccine may be viewed as a cause of autism, which is categorically untrue. This has led to increased global morbidity and misinformation about the safety and efficacy of vaccines, including the measles vaccine. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Management Case Study from the 2022 Midyear Clinical Meeting, content matter experts describe the process for developing an enterprise-wide acute hospital at home (AHH) program and identify the risks and benefits of AHH for the healthcare organization.as well as patients and caregivers. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a discussion of real-world examples for incorporating wellness activities into organizational efforts to support individual well-being and resilience. Guests will also discuss a vision for leveraging the pharmacy workforce in wellness-related patient care services as a means to promote health and advance the profession. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Stephen Small and Dr. Regis Lucia discuss the AJHP Commentary, “Obstetric clinical pharmacy: A necessary birth of a new specialty,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from 2022 Midyear Clinical Meeting, our content matter expert reviews key data analytics techniques, including machine learning, to promote drug diversion program best practices. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Leadership is often associated with a leader taking charge at the frontline. Oftentimes we describe these types of leaders as strong, inspirational, or courageous, however, the biggest impacts don’t always come from the individuals leading the charge. Although they sometimes go unrecognized, “Little L” leaders can be found scattered within the group where they work behind the scenes to empower their teammates and steer them towards success. That is why the concept of “leading from behind” is such a crucial component of ensuring effective team dynamics. If you apply this philosophy to the healthcare landscape, it becomes apparent that the nature of our profession allows pharmacists to act as a prime example of how this leadership style can be effectively utilized. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Acute agitation, particularly in patients with schizophrenia and bipolar disorder, occurs frequently, resulting in multiple visits to the emergency department each year. The management of acute agitation occurs in various departments throughout the hospital and health system. This educational activity will discuss currently recommended patient-centered approaches to care, which includes both nonpharmacologic and pharmacologic treatments. Guideline-recommended approaches that improve the patient experience as well as improve future interactions between patients and healthcare professionals will also be discussed. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode includes an interview with two ID specialty pharmacists and their take on the new Joint Commission requirements that were implemented in 2023. Tune in to learn what they anticipate to be the biggest challenges and opportunities they see from the perspective of a large academic and small community hospital. Show notes: R3 Report Antibiotic Stewardship: https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_antibioticstewardship_july2022_final.pdf The Joint Commission Antibiotic Stewardship Resources: https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/antibiotic-stewardship The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides an engaging interview with a seasoned pharmacy leader to provide listeners with an overview of successful project management. All too often, new leaders and frontline staff involved in projects can become overwhelmed with the steps involved to see a project through. Tina Do, of Yale New Haven Health, will take us through the basics of creating a strong project plan. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from the 2022 Midyear Clinical Meeting, our content matter expert reviews what artificial intelligence is (and isn’t) and identifies opportunities in health-system pharmacies where artificial intelligence (AI) can be used. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Mpox, formerly known as monkeypox, has been reported in all 50 states. The Navigators discuss how lessons learned from COVID-19 can be applied to manage this latest outbreak and provide insight on current efforts by departments of health and pharmacies to address this newest public health need. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Kenneth Komorny and Nicole Bennett discuss the AJHP Commentary, “Payer site of care mandates with oncology medications: It’s time to demand payer accountability on behalf of patients,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast, produced by ASHP’s Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), delivers an engaging interview with two distinguished pharmacy leaders who have embraced lifelong learning to serve the profession. Jordan Dow and Majid Tanas share their approaches and discuss the importance of lifelong learning. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

With the release of the revised USP <797> guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this third episode of the series, speakers will focus on one of the most significant changes between the currently enforceable version and the upcoming version: the change from low, medium, and high risk to category 1, 2, and 3 compounding and how this impacts BUDs. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

International interest in US-based pharmacy residency training has grown in recent years. With a reduced US pharmacy student pipeline, the desire for health-systems to hire international candidates into residencies is likely to increase. Many Pharmacy administrators and Resident Program Directors in the US are not familiar with visa restrictions for international trainees. This podcast will shed light on training visas and perspectives on this topic. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join this three-part conversation with Dr. Blake Porter, Dr. Shareen El-Ibiary, and Dr. Justin Konkol – experienced pharmacy educators, well-being leaders, and recent participants in ASHP’s Well-Being Ambassador Program. Each episode will discuss their journeys exploring and implementing WBR principles, while leading the way for their learners and organizations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Management Case Study from the 2022 Midyear Clinical Meeting, our content matter experts identify considerations for implementation of IV chemotherapy robotic technology into a cancer center’s care model, discuss methods to optimize IV chemotherapy robotic technology workflow integration and review benefits of using IV chemotherapy compounding robotic technology. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

With the release of the revised USP <797> guidance, it is important to revisit some of the basics of sterile compounding. The Section of Inpatient Care Practitioner’s SAG on Compounding Practice has developed a three-part series that will cover differing definitions of compounding, beyond use dates (BUDs), and changes from low, medium, and high risk compounding categories. In this second episode of the series, speakers will discuss details around beyond use dating assignments and how that applies to various types of products in our compounding practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, our content matter experts present recent changes to sterile and non-sterile compounding guidance in the USP chapters at the 2022 Midyear Clinical Meeting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Describe the keys to success for succession planning with the pharmacy enterprise to solidify a strong leadership team. Share internal and external tools available to engage emerging leaders to promote professional growth. Share success stories of individuals that have received the benefit of deliberate succession planning. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will focus on Pharmacoequity; what it is and ways to address it. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode from the 2022 Midyear Clinical Meeting, content matter experts discuss the ongoing database development focused on predicting drug event risks in pediatric patient. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, the team from the UNC Health to discuss their award winning submission to the ASHP Best Practices. They will share how they established a comprehensive Pharmacy Revenue Integrity program for outpatient medical benefit claims within pharmacy services, aligning financial, clinical and operational areas to ensure department and institutional long‐term financial strength. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In a short period of time, the “metaverse” has become a buzzword in the technology industry and beyond. The question in many people’s minds is, “when will the metaverse hit me?” Join us as we explore what the metaverse is today and how pharmacy could be impacted. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.